Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ACIU

AC Immune SA

Dec 07 • 04:00PM ET

3.51

Dollar change -0.06
Percentage change -1.68	%

Healthcare • Biotechnology • Switzerland • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.88	Insider Own	50.26%	Shs Outstand	83.62M	Perf Week	6.04%
Market Cap	293.51M	Forward P/E	-	EPS next Y	-0.57	Insider Trans	0.00%	Shs Float	41.59M	Perf Month	29.04%
Income	-74.24M	PEG	-	EPS next Q	0.02	Inst Own	19.95%	Short Float / Ratio	1.36% / 11.48	Perf Quarter	6.69%
Sales	0.00M	P/S	-	EPS this Y	29.55%	Inst Trans	1.20%	Short Interest	0.56M	Perf Half Y	58.11%
Book/sh	1.75	P/B	2.00	EPS next Y	13.34%	ROA	-40.66%	Target Price	10.82	Perf Year	52.61%
Cash/sh	1.04	P/C	3.36	EPS next 5Y	-	ROE	-44.93%	52W Range	1.68 - 3.83	Perf YTD	72.06%
Dividend	-	P/FCF	-	EPS past 5Y	-13.66%	ROI	-53.27%	52W High	-8.35%	Beta	0.67
Dividend %	-	Quick Ratio	7.36	Sales past 5Y	232.51%	Gross Margin	-	52W Low	108.93%	ATR	0.22
Employees	156	Current Ratio	7.36	Sales Q/Q	-100.00%	Oper. Margin	-7376960.89%	RSI (14)	65.96	Volatility	6.98% 6.58%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	-20.99%	Profit Margin	-7157319.53%	Rel Volume	1.72	Prev Close	3.57
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Nov 03 BMO	Payout	-	Avg Volume	49.23K	Price	3.51
Recom	1.00	SMA20	12.19%	SMA50	20.81%	SMA200	32.99%	Volume	84,866	Change	-1.68%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-01-19	Downgrade	UBS	Buy → Neutral
Jan-04-19	Initiated	UBS	Buy
Apr-05-18	Initiated	H.C. Wainwright	Buy	$18
Mar-23-18	Downgrade	Credit Suisse	Outperform → Neutral
Oct-18-16	Initiated	Leerink Partners	Outperform
Oct-18-16	Initiated	Jefferies	Buy	$25
Oct-18-16	Initiated	Credit Suisse	Outperform	$18

Dec-05-23 05:59AM	Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now? (Zacks)
Dec-01-23 07:00AM	AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO (GlobeNewswire)
Nov-28-23 07:33PM	Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth (InvestorPlace) +7.02%
Nov-20-23 06:00AM	FOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug success (Reuters)
Nov-07-23 07:00AM	AC Immune to Present at the Jefferies 2023 London Healthcare Conference (GlobeNewswire)
08:37AM	Loading…
Nov-03-23 08:37AM	AC Immune: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update (GlobeNewswire)
Nov-02-23 07:00AM	AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer's Disease as a Surrogate of Clinical Efficacy on November 9, 2023 (GlobeNewswire)
Oct-27-23 07:00AM	AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic (GlobeNewswire) -6.55%
Oct-24-23 09:40AM	Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year? (Zacks) +5.66%
Oct-23-23 10:00AM	Earnings Preview: Qiagen (QGEN) Q3 Earnings Expected to Decline (Zacks) +7.72%
Oct-20-23 10:00AM	AC Immune (ACIU) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks) -11.19%
Oct-18-23 08:26AM	NeoGenomics (NEO) Soars 8.9%: Is Further Upside Left in the Stock? (Zacks)
Oct-17-23 07:00AM	AC Immune Announces Upcoming Presentations at the 16th CTAD Conference (GlobeNewswire)
Oct-05-23 07:00AM	AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023 (GlobeNewswire)
01:09PM	Loading…
Sep-05-23 01:09PM	AC Immune (ACIU) Surges 43% in the Past 3 Months: Here's Why (Zacks)
08:48AM	Are Options Traders Betting on a Big Move in AC Immune (ACIU) Stock? (Zacks)
07:00AM	AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 (GlobeNewswire)
Aug-04-23 08:15AM	AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:14AM	AC Immune: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update (GlobeNewswire)
Jul-28-23 07:00AM	AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023 (GlobeNewswire)
Jul-26-23 07:00AM	AC Immune SA Appoints New Chief Medical Officer (GlobeNewswire)
Jul-03-23 07:00AM	AC Immune Showcasing Precision Medicine Programs at AAIC 2023 (GlobeNewswire)
Jun-30-23 03:13PM	Why Shares of AC Immune Jumped This Week (Motley Fool)
Jun-27-23 07:00AM	AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimers Disease (GlobeNewswire) +71.72%
Jun-23-23 04:30PM	AC Immune Holds Annual General Meeting of Shareholders (GlobeNewswire)
Jun-16-23 10:45AM	Private equity firms among AC Immune SA's (NASDAQ:ACIU) largest stockholders and were hit after last week's 12% price drop (Simply Wall St.)
May-04-23 09:02AM	Here's Why We're Watching AC Immune's (NASDAQ:ACIU) Cash Burn Situation (Simply Wall St.) +11.35%
Apr-28-23 07:14AM	AC Immune: Q1 Earnings Snapshot (AP Finance)
07:00AM	Loading…
07:00AM	AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update (GlobeNewswire)
Apr-26-23 08:01PM	7 Biotech Stocks With Huge Return Potential for Long-Term Investors (InvestorPlace) +6.25%
Apr-07-23 08:29AM	AC Immune (NASDAQ:ACIU) shareholders have endured a 76% loss from investing in the stock five years ago (Simply Wall St.)
Apr-05-23 07:00AM	AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimers Disease (GlobeNewswire)
Mar-20-23 08:00AM	AC Immune at AD/PD 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline (GlobeNewswire)
Mar-16-23 07:00AM	AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-08-23 07:00AM	AC Immune to Report Full Year 2022 Financial Results and Provide Corporate Update on March 16, 2023 (GlobeNewswire)
Feb-07-23 07:00AM	AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 (GlobeNewswire)
Feb-02-23 08:15AM	AC Immune to Present at the SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-27-23 09:57AM	Biogen (BIIB) & Eisai's Lecanemab Secures EMA's MAA Acceptance (Zacks)
Jan-26-23 07:00AM	AC Immunes ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimers Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial (GlobeNewswire)
Jan-18-23 07:00AM	AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimers Disease (GlobeNewswire)
Jan-07-23 08:45AM	AC Immune SA's (NASDAQ:ACIU) largest shareholders are private equity firms with 39% ownership, individual investors own 29% (Simply Wall St.)
Nov-30-22 07:00AM	AC Immunes Alzheimers Disease Vaccine-candidate ACI-35.030 Selected for Further Development (GlobeNewswire)
Nov-25-22 07:17AM	Will AC Immune (NASDAQ:ACIU) Spend Its Cash Wisely? (Simply Wall St.) +7.39%
Nov-23-22 07:30AM	AC Immune to Present Progress of Alzheimers Disease Programs targeting Abeta and Tau at the 15th CTAD Conference (GlobeNewswire)
Nov-08-22 07:58AM	AC Immune to Present at the Jefferies London Healthcare Conference (GlobeNewswire) -5.02%
Oct-29-22 08:06AM	Shareholders in AC Immune (NASDAQ:ACIU) are in the red if they invested five years ago (Simply Wall St.)
Oct-28-22 09:25AM	AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.61%
08:00AM	AC Immune Reports Third Quarter 2022 Financial Results and Provides a Corporate Update (GlobeNewswire)
Oct-04-22 08:36AM	AC Immune Opens New Centers in Phase 1b/2 Trial Evaluating ACI-24 Targeting Abeta in Alzheimers Disease and Down Syndrome (GlobeNewswire)
Sep-26-22 07:30AM	AC Immune Partner LMI Progresses Tau PET Tracer PI-2620 into Late-stage Development in Alzheimers Disease (GlobeNewswire)
Sep-01-22 08:00AM	AC Immune Receives a Grant from The Michael J. Fox Foundation for Continued Development of Parkinsons Disease Diagnostic Imaging Agent (GlobeNewswire)
Aug-24-22 04:05PM	AC Immune KOL Webinar on the Potential Benefits of Vaccines for Alzheimers and Parkinsons Diseases (GlobeNewswire)
Aug-11-22 07:30AM	AC Immune to Host Key Opinion Leader Webinar on Vaccinations to Treat and Prevent Alzheimers and Parkinsons Diseases (GlobeNewswire) -5.52%
Aug-02-22 11:00AM	Detailed Data From the Phase II Crenezumab Alzheimers Prevention Initiative Study in Autosomal Dominant Alzheimers Disease Presented at AAIC (GlobeNewswire)
Jul-31-22 08:12AM	What Type Of Shareholders Own The Most Number of AC Immune SA (NASDAQ:ACIU) Shares? (Simply Wall St.)
Jul-28-22 08:45AM	AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:30AM	AC Immune Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-22-22 07:30AM	AC Immune Announces Upcoming Presentations at the Alzheimers Association International Conference (GlobeNewswire)
Jun-24-22 04:30PM	AC Immune Holds Annual General Meeting of Shareholders (GlobeNewswire)
Jun-21-22 10:35AM	10 Unknown Biotech Stocks That Can Explode in 2022 (Insider Monkey) +15.00%
Jun-17-22 08:31AM	Roche Alzheimer's Candidate Failure Hurts Lilly, Biogen (Zacks) +10.64%
Jun-16-22 08:20AM	Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients (Benzinga) -17.83%
06:39AM	AC Immune shares slide 15% premarket after trial of Alzheimer's treatment misses its main goals (MarketWatch)
01:00AM	AC Immune Provides Update on Alzheimers Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimers Disease (GlobeNewswire)
Jun-01-22 08:26AM	We're Not Very Worried About AC Immune's (NASDAQ:ACIU) Cash Burn Rate (Simply Wall St.)
May-31-22 07:30AM	AC Immune to Present at the 2022 Jefferies Healthcare Conference (GlobeNewswire)
May-17-22 09:00AM	AC Immune CEO Andrea Pfeifer Receives Aenne Burda Award (GlobeNewswire)
May-09-22 11:00AM	AC Immunes Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology (GlobeNewswire) -12.31%
Apr-28-22 07:30AM	AC Immune Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-27-22 07:55AM	AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference (GlobeNewswire) -6.25%
Apr-08-22 07:30AM	AC Immune Reports Changes to Senior Management (GlobeNewswire) -6.78%
Mar-30-22 07:58AM	AC Immune KOL Webinar on First Clinical Proof of Concept for Alpha-synuclein Diagnostic Shows Breakthrough Potential for Neurodegenerative diseases (GlobeNewswire) -6.46%
Mar-22-22 07:30AM	AC Immune Reports Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-21-22 07:30AM	AC Immune to Host Key Opinion Leader Webinar on Alpha-Synuclein as a Target in Neurodegenerative Diseases (GlobeNewswire)
Mar-16-22 07:41AM	AC Immune Reports First Live Images of Alpha-Synuclein in Human Brain with New PET Tracer for Neurodegenerative Disease at AD/PDTM Conference (GlobeNewswire)
Feb-28-22 07:30AM	AC Immune to Present at the AD/PD 2022 New Clinical and Preclinical Data for Alpha-Synuclein, Abeta and TDP-43 Programs (GlobeNewswire)
Feb-21-22 04:30AM	Could The AC Immune SA (NASDAQ:ACIU) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Feb-15-22 02:54PM	AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial (Benzinga)
07:30AM	AC Immune ACI-35.030 Phase 1b/2a Trial Interim Data Confirm Consistent Safety and Potent Immunogenicity of pTau Alzheimers Vaccine in High-dose Cohort (GlobeNewswire)
Feb-04-22 07:30AM	AC Immune ACI-24 Data in Brain Communications Show Abeta Vaccine-Candidate Induces Immunity Against pyroGlu-Abeta, Key Driver of Alzheimers Disease (GlobeNewswire)
Feb-02-22 08:58AM	AC Immune to Present at the SVB Leerink 11th Annual Global Healthcare Conference (GlobeNewswire)
Dec-15-21 07:49AM	AC Immune Awarded Two Michael J. Fox Foundation Grants to Advance Small Molecule Parkinsons Disease Programs (GlobeNewswire)
Nov-15-21 06:01AM	10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund (Insider Monkey)
Nov-12-21 08:21AM	AC Immune Announces Interim Phase 1b/2a Data Showing that its ACI-35.030 Anti-pTau Alzheimers Vaccine Generates a Potent Immune Response (GlobeNewswire)
Nov-10-21 11:20AM	AC Immune Announces Late-Breaker Presentation by Genentech at CTAD on Phase 2 Lauriet Study of Semorinemab in Mild-to-Moderate Alzheimers Disease (GlobeNewswire) -19.18%
Nov-08-21 08:25AM	AC Immune (ACIU) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:00AM	AC Immune Reports Third Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-07-21 07:53AM	AC Immune says number of families affected by Alzheimer's could nearly triple by 2050 (Reuters)
Nov-05-21 03:00PM	Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline (Zacks)
Nov-04-21 06:00AM	AC Immune Extends Research Collaboration with University of Pennsylvania Focusing on the Pathogenic Protein TDP-43, a Major Driver of Neurodegenerative Diseases (GlobeNewswire)
Nov-02-21 07:30AM	New Data on AC Immunes Abeta and pTau Clinical Programs in Alzheimers Disease To Be Presented at CTAD 2021 (GlobeNewswire) +6.15%
Oct-29-21 06:00AM	AC Immune Holds its Extraordinary General Meeting and Appoints Monica Shaw, M.D., and Prof. Monika Bütler, Dr. oec., to its Board of Directors (GlobeNewswire)
Oct-25-21 07:00AM	AC Immune to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-24-21 08:04AM	Shareholders in AC Immune (NASDAQ:ACIU) are in the red if they invested five years ago (Simply Wall St.)
Sep-03-21 07:52AM	AC Immune CEO Andrea Pfeifer Receives First SEF.WomenAward for CEO of the Year (GlobeNewswire)
Sep-02-21 07:00AM	AC Immune to Participate in Upcoming Virtual Investor Conferences in September (GlobeNewswire)
Sep-01-21 11:30AM	AC Immune's (ACIU) Stock Up Despite Mixed Data From AD Study (Zacks) -10.33%
10:44AM	Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More (Zacks)

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACIU

AC Immune SA

Upgrade your FINVIZ experience